Table 1.
LAPSN pseudotype | LAPSN vector titer on NIH 3T3
cells expressing the following receptors,
cfu/ml
|
LAPSN vector titer on CHO cells expressing
the following receptors, cfu/ml
|
|||||
---|---|---|---|---|---|---|---|
None | Xenotropic | RD114/type D | None | Xenotropic | RD114/type D | Amphotropic | |
Xenotropic | <2 | 4 × 104 | <2 | 50 | 1.5 × 106 | 30 | 20 |
Polytropic | 1.5 × 108 | 2 × 108 | 1.5 × 108 | <2 | 2 × 104 | <2 | <2 |
Amphotropic | 6 × 106 | 8 × 106 | 9 × 106 | <2 | <2 | <2 | 4 × 106 |
RD114 | <2 | <2 | 2 × 104 | <2 | <2 | 3 × 103 | <2 |
GALV | <2 | <2 | <2 | 60 | 50 | 50 | 20 |
NIH 3T3 and CHO cells expressing the XPR1 xenotropic, RD114/type D (31), amphotropic (26), or no exogenous receptor (empty vector only) were generated by transduction of the cells with L(XPR1)SN, L(RDR)SN, L(Pit2)SN, or LXSN, respectively, followed by selection in G418 to generate polyclonal populations. For assay, 105 target cells were plated in 35-mm-diameter dishes on day 1. On day 2, the medium was replaced with 1 ml of medium containing 4 μg/ml Polybrene and serial dilutions of indicated pseudotypes of the LAPSN vector. Cells were stained for alkaline phosphatase+ foci on day 4 as described (26). Results are average values from duplicate dishes in a representative experiment.